Saturday 17 October 2026 Export DARE’s income statement to Excel — free account

Dare Bioscience, Inc.

Dare Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, up 10,412.2% from fiscal 2024. In the quarter to June 2026, revenue grew 984.4%, EPS grew 55.6% and free cash flow fell 30.2%, each against the same quarter a year earlier.

0.72 0.02 −2.70%

Follow DARE

Alert me

Market cap: $14.6M
P/E: 0.0×
Fwd P/E: −2.0×
Dividend yield: —
F-score: 4/9
Altman Z: −8.92
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	23.00	22.84	20.94	0.00
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(4.64)	(4.79)	14.94	(60.59)
P/B ratio Full definition →	0.00	36.02	7.59	9.37
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	19.88	14.06	5.07	(211.34)
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(2.40)	(1.64)	(0.53)	(2.00)
EV/FCF Full definition →	(2.34)	(1.58)	(0.51)	(1.78)
Quick Ratio Full definition →	0.77	0.91	1.07	1.11
Current Ratio Full definition →	0.99	1.03	1.14	1.18
Net Debt/EBITDA Full definition →	5.27	7.58	23.04	7.47
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.54%
Debt/Equity Full definition →	0.00	0.00	0.00	0.06
Asset Turnover Full definition →	0.08	0.05	0.04	0.00
Operating CF/Net income Full definition →	2.27	1.84	(1.00)	0.12
Capex/Depreciation Full definition →	(0.14)	0.00	(0.52)	(0.29)
Research and Development Expense of Revenue Full definition →	129.07%	433.11%	60.76%	51,095.65%
Selling, General and Administrative Expense of Revenue Full definition →	1,383.31%	1,474.49%	154.06%	108,660.87%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	152.85%	298.43%	34.89%	17,521.74%
Graham Net Nets Full definition →	(0.20)	(0.21)	(0.12)	(0.11)
Graham Number Full definition →	0.77	0.00	0.00	0.00
Earnings Yield Full definition →	(33.18%)	(52.20%)	(64.77%)	(89.05%)
Free Cash Flow Yield Full definition →	(36.93%)	(39.05%)	(47.61%)	(25.26%)
Revenue per Share Full definition →	0.01	0.01	0.09	0.00
Operating CF per Share Full definition →	(0.45)	(0.38)	0.13	(0.03)
Capex per Share Full definition →	(0.01)	0.00	(0.02)	(0.01)
Free Cash Flow per Share Full definition →	(0.46)	(0.38)	0.11	(0.05)
Cash per Share Full definition →	0.85	1.28	2.21	1.81
Shareholders Equity per Share Full definition →	(0.04)	0.05	0.25	0.22
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	(0.04)	0.05	0.25	0.22
Free Cash Flow Full definition →	(6.86)	(5.52)	1.24	(0.62)
Working Capital Full definition →	(0.24)	0.54	3.38	3.79
Capital Expenditures Full definition →	(0.08)	—	(0.21)	(0.17)
Net Current Asset Value Full definition →	(6.24)	(5.43)	(2.57)	(2.89)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.43	0.00	0.20	75.96
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.32	0.40	0.40	0.44
Average Payables Full definition →	1.26	1.56	1.33	1.45
Average Assets Full definition →	17.67	23.22	27.29	24.40
Average Common Equity Full definition →	(6.65)	(4.41)	(1.58)	0.69

Fold the line items

Columns are period end dates

Stockrow Weekly